ABVC BioPharma Inc (ABVC)
0.5306
0.00 (0.00%)
USD |
NASDAQ |
Nov 14, 12:15
ABVC BioPharma Profit Margin (Quarterly): -864.5% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -864.5% |
| March 31, 2024 | -326.4K% |
| December 31, 2023 | -143.7K% |
| September 30, 2023 | -20.89K% |
| June 30, 2023 | -37.05K% |
| March 31, 2023 | -1.42K% |
| December 31, 2022 | -825.8% |
| September 30, 2022 | -8.76K% |
| June 30, 2022 | -594.2% |
| March 31, 2022 | -23.36K% |
| December 31, 2021 | |
| September 30, 2021 | -1.82K% |
| June 30, 2021 | -6.27K% |
| March 31, 2021 | -428.8% |
| December 31, 2020 | -7.80K% |
| September 30, 2020 | -1.60K% |
| June 30, 2020 | -816.4% |
| March 31, 2020 | -1.58K% |
| December 31, 2019 | -1.08K% |
| September 30, 2019 | -614.4% |
| June 30, 2019 | -290.7% |
| March 31, 2019 | -373.0% |
| December 31, 2018 | |
| September 30, 2018 | -76.41K% |
| June 30, 2018 | -19.58K% |
| Date | Value |
|---|---|
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | -2.81K% |
| June 30, 2015 | |
| March 31, 2015 | 49.51% |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | -13.70K% |
| December 31, 2012 | -2.19K% |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | -9.35K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-326.4K%
Minimum
Mar 2024
-428.8%
Maximum
Mar 2021
-32.51K%
Average
-1.71K%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -176.9% |
| Return on Assets | -81.83% |
| Return on Invested Capital | -129.8% |
| Gross Profit Margin (Quarterly) | 99.84% |
| Operating Margin (Quarterly) | -833.7% |
| Return on Net Operating Assets | -136.6% |